Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:** This compound is a synthetic chemical entity featuring the core structure of pyrazolotriazine substituted at multiple positions. It is not currently marketed as a drug and does not have an established clinical indication or mechanism of action in the literature. The compound appears in chemical databases such as PubChem and Pharos but lacks detailed pharmacological or clinical data. Its molecular formula is C19H14ClN7 and its molecular weight is approximately 375.8 g/mol.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-(4-chlorobenzylamino)-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile.